Leállítva2. fázis
Comparative Imaging of XTR004 PET and MIBI SPECT in Borderline Coronary Stenosis
A legfontosabb adatok
- Ki végzi
- Sinotau Pharmaceutical Group
- Hol
- Kína1 helyszín, 1 országbanVálassz országot a helyszínekhez
- Azonosító
- Állapot
- Leállítva
- Fázis
- 2. fázis
- Résztvevők
- 17 fő vett részt
- Kezdés
- 2024. dec. 19.
- Befejezés
- 2025. márc. 5.
- A vizsgálat típusa
- Beavatkozással járó
- A vizsgált kezelések
- XTR004
- A regiszteradat frissítve
- 2026. január 12.
- Miért állt le
- The main objective of this study has been achieved. Following internal discussions, the sponsor has decided to terminate this study early.
Ki vehet részt
- Életkor
- 18 év felett
- Nem
- Nők és férfiak
- Egészséges önkéntesek
- Nem vehetnek részt
A regiszter feltételei, szó szerint
Mind a 15 feltétel megnézéseKevesebb
Ki vehet részt
- 1.Male or female participants aged 18 years or older
- 2.Suspected or known stable coronary artery disease with related symptoms and stable condition, and having at least one coronary artery disease risk factor, including: hypertension, hyperlipidemia, diabetes, obesity, alcohol abuse, smoking, family history of coronary artery disease, postmenopausal status in women, or advanced age
- 3.Underwent coronary CTA within the past 6 months showing 30%-90% stenosis, or indicating mild to moderate-to-severe stenosis
- 4.Able to communicate effectively with the investigators, understand and comply with the clinical study requirements, voluntarily participate in the study, and provide written informed consent
Ki nem vehet részt
- 2.Patients with a prior diagnosis of myocardial infarction, congenital heart disease, cardiomyopathy, myocarditis, or other cardiac diseases
- 6.Individuals with significant occupational exposure to ionizing radiation within the past 10 years (e.g., exceeding 50 mSv/year), or exposure to radioactive substances or ionizing radiation for therapeutic or research purposes
- 10.Patients who participated in another investigational drug clinical study within 30 days prior to enrollment or plan to do so during follow-up
- 1. Patients with a history of percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG)
- 3.Patients known to have severe allergic reactions to alcohol
- 4.Patients known to have an allergy or other contraindications to adenosine
- 5.Patients known to be allergic to iodinated contrast agents
- 9.Patients with claustrophobia, bipolar disorder, other psychiatric disorders, or poor compliance
- 11.Any other condition that, in the opinion of the investigators, makes the patient unsuitable for participation
- 7.Men and women of childbearing potential who do not plan to use effective contraception during the study and for 6 months after study completion (effective methods include sterilization, intrauterine hormonal devices, condoms, contraceptive pills/agents, abstinence, or partner vasectomy/tubal ligation)
- 8.Pregnant or lactating women
Ennek a vizsgálatnak nincs helyszíne itt: Egyesült Államok.
Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.
A vizsgálatról
Mit akar kideríteni a vizsgálat
Compare the diagnostic certainty of MIBI SPECT myocardial perfusion imaging (MPI) and XTR004 PET MPI.
A vizsgálat csoportja
- XTR004 MPI PET & MIBI SPECT MPIA vizsgált kezelés
Patients with suspected or known stable coronary artery disease who have previously undergone coronary CTA showing 30%-80% stenosis in any coronary vessel, or mild to moderate stenosis, will be enrolled and sequentially undergo MIBI SPECT myocardial perfusion imaging (MPI) and XTR004 PET MPI
Kezelés: XTR004
Adatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- Comparative Imaging Study of PET Myocardial Perfusion With XTR004 Injection Versus MIBI SPECT in Patients With Borderline Coronary Stenosis
- A regiszteradat frissítve
- 2026. január 12.